Cambridge Regulatory Services

From Verify.Wiki
Jump to: navigation, search
QuickUpload1085 20170606231428.png
[1]
Type Private
Industry Regulatory Affairs, MAA, eCTD, Pharmacovigilance, DCP, Readability testing, and PIL user testing
Founded 1999
Headquarters 2 Cabot House

Compass Point Business Park St Ives PE27 5JL Cambridgeshire (UK)

Number of employees 11-50 employees

Overview

Cambridge Regulatory Services is a full service regulatory affairs consultancy helping pharmaceutical companies get their medicines to market faster. Help comes in many forms including advice, strategic planning, dossier preparation, management of submissions and all compliance issues.

The company is proud of the many benefits in working with them which are as follows:

- Fixed price option available

- Service Continuity

- Project Progress Reports

- Knowledgeable and experienced team (including Ex Regulators)

- World Wide cover

- Delivering your projects on time

Cambridge Regulatory Services has gained a reputation for delivering projects on time and within budget for its clients across the world.

Relentlessly striving to exceed their clients’ expectations, Cambridge Regulatory Services enables you to remain focused on your key objectives whilst our team of professionals takes care of your short-term or long-term regulatory needs.

Controversies

Top 5 Recent Tweets

DateAuthorComment
November 12, 2018ggariukHave PTAs gone too far in their quest to iron out regulatory divergences in services? I review relevant trade disci… https://t.co/O2eJQU3fSX


Top 5 Recent News Headlines

1. EMA Regulatory Guidance for industry to prepare for the UK’s withdrawal from the EU

Thursday 1st of June 2017 - http://www.cambreg.co.uk/news/ema-regulatory-guidance-industry-prepare-uks-withdrawal-eu/

The European Medicines Agency (EMA) and the European Commission have published guidance to help pharmaceutical companies to prepare for the United Kingdom's withdrawal from the European Union. The guidance relates to both human and veterinary medicines.

2. EMA Notice to marketing authorisation holders of centrally authorised medicinal products for human and veterinary use

Marketing authorisation holders of centrally authorised medicinal products for human and veterinary use are reminded of certain legal repercussions, which need to be considered.

Wednesday 3rd of May 2017 - http://www.cambreg.co.uk/news/ema-notice-marketing-authorisation-holders-centrally-authorised-medicinal-products-human-and-veterinary-use/

3. New MedRegs blog

MHRA has launched an official blog providing expert insight into the latest regulatory thinking and all aspects of medicines regulation.

Thursday 9th of February 2017 - http://www.cambreg.co.uk/news/changes-mhra-payment-fees/

Top 5 Lifetime Tweets

Top 5 Lifetime News Headlines

References

https://www.linkedin.com/company-beta/1041149/

http://www.cambreg.co.uk/about-us/

Verification history